Everand Logo

Welcome to Everand!

  • STAT

    Sam Isaly leaves OrbiMed months after harassment allegations

    More than four months after promising to resign, Sam Isaly has stepped down from biotech’s most powerful hedge fund in the wake of allegations of rampant sexual harassment.
    by Damian Garde Apr 27, 2018 1 minute

    More than four months after from biotech’s most powerful hedge fund, Sam Isaly has stepped down from in the wake of allegations of rampant sexual harassment.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
    The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.